Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change $ Change
grade F $1.26 -1.56% -0.02
ACST closed down 1.56 percent on Friday, January 13, 2017, on 26 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ACST trend table...

Date Alert Name Type % Chg
Jan 13 Calm After Storm Range Contraction 0.00%
Jan 13 Narrow Range Bar Range Contraction 0.00%
Jan 13 NR7 Range Contraction 0.00%
Jan 12 Calm After Storm Range Contraction -1.56%
Jan 12 Fell Below 50 DMA Bearish -1.56%
Jan 11 Expansion Pivot Buy Setup Bullish Swing Setup -8.70%
Jan 11 Stochastic Buy Signal Bullish -8.70%
Jan 11 Shooting Star Candlestick Bearish -8.70%
Jan 11 Wide Range Bar Range Expansion -8.70%
Jan 11 Volume Surge Other -8.70%

Older signals for ACST ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 3 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.09
52 Week Low 1.11
Average Volume 230,138
200-Day Moving Average 1.45
50-Day Moving Average 1.31
20-Day Moving Average 1.27
10-Day Moving Average 1.28
Average True Range 0.15
ADX 41.65
+DI 40.0
-DI: 11.43
Chandelier Exit (Long, 3 ATRs) 1.58
Chandelier Exit (Short, 3 ATRs) 1.56
Upper Bollinger Band 1.44
Lower Bollinger Band 1.1
Percent B (%b) 0.47
Bandwidth 0.267717